Table of Contents

- J R Gavin, 3rd
Good news in diabetes.
Diabetes December 1994 43:1391-1393
Select this article
- D E Moller
Transgenic approaches to the pathogenesis of NIDDM.
Diabetes December 1994 43:1394-1401; doi:10.2337/diabetes.43.12.1394
- Abstract
Select this article
- A Wajngot,
- M Alvarsson,
- A Glaser,
- S Efendic,
- H Luthman,
- and V Grill
Glucose potentiation of arginine-induced insulin secretion is impaired in subjects with a glucokinase Glu256Lys mutation.
Diabetes December 1994 43:1402-1406; doi:10.2337/diabetes.43.12.1402
- Abstract
Select this article
- L A Gonder-Frederick,
- D J Cox,
- N R Driesen,
- C M Ryan,
- and W L Clarke
Individual differences in neurobehavioral disruption during mild and moderate hypoglycemia in adults with IDDM.
Diabetes December 1994 43:1407-1412; doi:10.2337/diabetes.43.12.1407
- Abstract
Select this article
- D Knaack,
- D M Fiore,
- M Surana,
- M Leiser,
- M Laurance,
- D Fusco-DeMane,
- O D Hegre,
- N Fleischer,
- and S Efrat
Clonal insulinoma cell line that stably maintains correct glucose responsiveness.
Diabetes December 1994 43:1413-1417; doi:10.2337/diabetes.43.12.1413
- Abstract
Select this article
- F Féry and
- E O Balasse
Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.
Diabetes December 1994 43:1418-1425; doi:10.2337/diabetes.43.12.1418
- Abstract
Select this article
- S Dagogo-Jack,
- C Rattarasarn,
- and P E Cryer
Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.
Diabetes December 1994 43:1426-1434; doi:10.2337/diabetes.43.12.1426
- Abstract
Select this article
- M K Lee,
- P D Miles,
- M Khoursheed,
- K M Gao,
- A R Moossa,
- and J M Olefsky
Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
Diabetes December 1994 43:1435-1439; doi:10.2337/diabetes.43.12.1435
- Abstract
Select this article
- C Y Jeng,
- W H Sheu,
- M M Fuh,
- Y D Chen,
- and G M Reaven
Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM.
Diabetes December 1994 43:1440-1444; doi:10.2337/diabetes.43.12.1440
- Abstract
Select this article
- A D Morris,
- J R Petrie,
- S Ueda,
- J M Connell,
- H L Elliott,
- M Small,
- and R Donnelly
Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects.
Diabetes December 1994 43:1445-1449; doi:10.2337/diabetes.43.12.1445
- Abstract
Select this article
- M A Hill and
- E A Ege
Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats. Effect of aminoguanidine treatment.
Diabetes December 1994 43:1450-1456; doi:10.2337/diabetes.43.12.1450
- Abstract
Select this article
- D A D'Alessio,
- C B Verchere,
- S E Kahn,
- V Hoagland,
- D G Baskin,
- R D Palmiter,
- and J W Ensinck
Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse.
Diabetes December 1994 43:1457-1461; doi:10.2337/diabetes.43.12.1457
- Abstract
Select this article
- S C Bain,
- B R Rowe,
- A H Barnett,
- and J A Todd
Parental origin of diabetes-associated HLA types in sibling pairs with type I diabetes.
Diabetes December 1994 43:1462-1468; doi:10.2337/diabetes.43.12.1462
- Abstract
Select this article
- Y Ido,
- J McHowat,
- K C Chang,
- E Arrigoni-Martelli,
- Z Orfalian,
- C Kilo,
- P B Corr,
- and J R Williamson
Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine.
Diabetes December 1994 43:1469-1477; doi:10.2337/diabetes.43.12.1469
- Abstract
Select this article
- J S Petersen,
- A E Karlsen,
- H Markholst,
- A Worsaae,
- T Dyrberg,
- and B Michelsen
Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice.
Diabetes December 1994 43:1478-1484; doi:10.2337/diabetes.43.12.1478
- Abstract
Select this article
- M Rewers,
- M I Kamboh,
- S Hoag,
- S M Shetterly,
- R E Ferrell,
- and R F Hamman
ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study.
Diabetes December 1994 43:1485-1489; doi:10.2337/diabetes.43.12.1485
- Abstract
Select this article
- S M Haffner,
- R R Bowsher,
- L Mykkänen,
- H P Hazuda,
- B D Mitchell,
- R A Valdez,
- R Gingerich,
- A Monterossa,
- and M P Stern
Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM.
Diabetes December 1994 43:1490-1493; doi:10.2337/diabetes.43.12.1490
- Abstract
Select this article
- J F Elliott,
- H Y Qin,
- S Bhatti,
- D K Smith,
- R K Singh,
- T Dillon,
- J Lauzon,
- and B Singh
Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice.
Diabetes December 1994 43:1494-1499; doi:10.2337/diabetes.43.12.1494
- Abstract

Good news in diabetes.

Transgenic approaches to the pathogenesis of NIDDM.

Glucose potentiation of arginine-induced insulin secretion is impaired in subjects with a glucokinase Glu256Lys mutation.

Individual differences in neurobehavioral disruption during mild and moderate hypoglycemia in adults with IDDM.

Clonal insulinoma cell line that stably maintains correct glucose responsiveness.

Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.

Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.

Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.

Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM.

Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects.

Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats. Effect of aminoguanidine treatment.

Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse.

Parental origin of diabetes-associated HLA types in sibling pairs with type I diabetes.

Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine.

Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice.

ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study.

Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM.

Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice.

This Issue

Current Issue